NO983650L - Krystallinske progestagener - Google Patents

Krystallinske progestagener

Info

Publication number
NO983650L
NO983650L NO983650A NO983650A NO983650L NO 983650 L NO983650 L NO 983650L NO 983650 A NO983650 A NO 983650A NO 983650 A NO983650 A NO 983650A NO 983650 L NO983650 L NO 983650L
Authority
NO
Norway
Prior art keywords
crystalline
compounds
progestagens
compound
progestagen
Prior art date
Application number
NO983650A
Other languages
English (en)
Norwegian (no)
Other versions
NO983650D0 (no
Inventor
Wilhelmus Petrus Hubertu Wildt
Maria Jacoba Adriana Va Schans
Cornelis Johannus Booy
Franciscus Theodorus Le Brands
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO983650D0 publication Critical patent/NO983650D0/no
Publication of NO983650L publication Critical patent/NO983650L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO983650A 1997-08-11 1998-08-10 Krystallinske progestagener NO983650L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202472 1997-08-11

Publications (2)

Publication Number Publication Date
NO983650D0 NO983650D0 (no) 1998-08-10
NO983650L true NO983650L (no) 1999-02-12

Family

ID=8228632

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983650A NO983650L (no) 1997-08-11 1998-08-10 Krystallinske progestagener

Country Status (20)

Country Link
US (1) US20020010166A1 (ko)
JP (1) JPH11116595A (ko)
KR (1) KR19990023484A (ko)
CN (1) CN1208043A (ko)
AR (1) AR015146A1 (ko)
AU (1) AU740229B2 (ko)
BR (1) BR9803129A (ko)
CA (1) CA2244619A1 (ko)
CO (1) CO4960661A1 (ko)
CZ (1) CZ252798A3 (ko)
HU (1) HUP9801850A3 (ko)
ID (1) ID21262A (ko)
IL (1) IL125503A0 (ko)
NO (1) NO983650L (ko)
NZ (1) NZ331197A (ko)
PE (1) PE105899A1 (ko)
PL (1) PL327915A1 (ko)
SG (1) SG66491A1 (ko)
TR (1) TR199801520A1 (ko)
ZA (1) ZA986943B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000050041A1 (en) * 1999-02-24 2000-08-31 Akzo Nobel N.V. Pharmaceutical compositions containing a crystalline form of the progestagen-(17alpha)-17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-20-yn-3-one (org 30659) and lactose

Also Published As

Publication number Publication date
CA2244619A1 (en) 1999-02-11
ID21262A (id) 1999-05-12
HUP9801850A3 (en) 2000-01-28
CN1208043A (zh) 1999-02-17
KR19990023484A (ko) 1999-03-25
PL327915A1 (en) 1999-02-15
HUP9801850A2 (hu) 1999-04-28
JPH11116595A (ja) 1999-04-27
TR199801520A1 (xx) 1999-02-22
CO4960661A1 (es) 2000-09-25
AU7896698A (en) 1999-02-18
IL125503A0 (en) 1999-03-12
CZ252798A3 (cs) 1999-06-16
BR9803129A (pt) 2000-05-02
AR015146A1 (es) 2001-04-18
ZA986943B (en) 1999-02-04
US20020010166A1 (en) 2002-01-24
PE105899A1 (es) 1999-10-30
HU9801850D0 (en) 1998-10-28
NO983650D0 (no) 1998-08-10
NZ331197A (en) 1998-11-25
SG66491A1 (en) 1999-07-20
AU740229B2 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
MXPA02011632A (es) Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1.
NO20052130L (no) Sterk inhibitor for HCV-serin-protease
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
NZ514574A (en) Novel method of treatment
DK1446128T3 (da) Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
DK1206467T3 (da) N-heterocykliske derivater som NOS-inhibitorer
AU1266900A (en) Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumors
KR970010784A (ko) 11-(치환된 페닐)-에스트라-4,9-디엔 유도체
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
DK0712311T3 (da) Antiglucocorticoidsteroider til behandling af angstlidelser
AP2003002716A0 (en) Medicinal compositions containing propenone derivatives.
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
PL374317A1 (en) Composition containing an androgenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BR0009476A (pt) Esteróides imunomoduladores, em particular hemidrato de 16 alfa-bromoepiandrosterona
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
UA85203C2 (en) 17β HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
NO983650L (no) Krystallinske progestagener
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BR0312123A (pt) Agentes de gnrh não peptìdicos, composições farmacêuticas e métodos para o seu uso
DE69525181D1 (de) Tnf-rezeptor und steroidhormon dhea in einer kombinationstherapie

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application